Lin, Yan-Song https://orcid.org/0000-0001-6095-4728
Yang, Hui
Li, Xiao-Yi
Wu, Li-Qing
Xu, Jin-Guo
Yang, Ai-Min
Gao, Zai-Rong
Ding, Yong
Zhang, Ying-Qiang
Chen, Kai
Mu, Zhuan-Zhuan
Jia, Jian-Min
Niu, Na
Sun, Di
Zhang, Xin
Zhang, Shao-Qiang
Geng, Qian-Qian
Zhang, Ya-Jing
Chen, Fang-Ni
He, Bao-Xia
Funding for this research was provided by:
Project on Inter-Governmental International Scientific and Technological Innovation Cooperation in the National Key Projects of Research and Development Plan (2019YFE0106400)
Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019XK320009)
Suzhou Zelgen Biopharmaceuticals Co., Ltd
Article History
Received: 8 February 2022
Accepted: 5 June 2022
First Online: 4 July 2022
Declarations
:
: This study was approved by the ethical board of each participating clinical institution. The research was performed with adherence to the guidelines of the Declaration of Helsinki.
: Patients gave informed consent, which included the use of pseudoanonymized data and samples for the purpose of research and publication.
: All authors have read the manuscript and agree with its publication.
: The authors declare no competing interests.